Indigenization: Self-Reliant S&T

1. RATIONALE, R&D BASE & FUNDING ARCHITECTURE

Cue Words	Notes
Why Indigenize: Strategic Rationale	Indigenization means **developing locally** what was previously imported, especially in strategic/dual-use sectors (defence, space, semiconductors, pharma) — reducing exposure to sanctions, supply-chain shocks, and licensing constraints. **R&D Expenditure (GERD)**: India spends only **~0.64% of GDP on R&D**, against 2.4% in China and 3.4% in the United States — the core resource constraint behind slow indigenization. **Private Sector R&D Contribution**: Private industry funds only **~37% of national R&D outlays**, with government funding the remaining 63% — an inversion of the pattern in advanced economies where private capital leads.
Institutional Funding Architecture	**Anusandhan National Research Foundation (ANRF)**: Created in 2023 with an outlay of **₹50,000 Crore** to fund basic science and applied R&D, explicitly designed to crowd in private capital via a governing board with industry representation. **Science & Engineering Research Board (SERB)**: Statutory body funding **25,000+ academic researchers** annually, now subsumed under ANRF's overall architecture. **DSIR Technology Development Scheme**: Financed development of **250+ indigenized commercial technologies** under public grants, bridging lab-to-market gaps.

> **Summary**: India's indigenization drive is constrained less by scientific talent than by capital — GERD at 0.64% of GDP and a government-heavy funding mix — so newer vehicles (ANRF, DSIR schemes) are structured explicitly to pull in private R&D spending rather than just add public grants.

2. DEFENCE INDIGENIZATION: NEGATIVE LISTS & DAP 2026

Cue Words	Notes
Positive/Negative Indigenization Lists	**Negative Import Lists**: MoD has notified successive lists (400+ items in early tranches, expanded to **4,600+ military items** overall) that cannot be imported, forcing local sourcing by services and PSUs. **Sovereign Platform Successes**: LCA Tejas, INS Vikrant (indigenous aircraft carrier), and the Agni/Akash missile families (DRDO & HAL) demonstrate end-to-end domestic design-build capability.
DAP 2026: From 'Made in India' to 'Owned by India'	The Ministry of Defence's draft Defence Acquisition Procedure (DAP) 2026 restructures procurement categories, removing the standalone "Buy (Indian)" route and placing structural priority on Buy (Indian-IDDM) — Indigenously Designed, Developed and Manufactured — as the default category. The stated shift is from "Made in India" (assembly/licensed production) to "Owned by India" — prioritising Indian ownership of IP, source code, critical design data, and upgrade authority, not just manufacturing location. FY2026-27 capital procurement is budgeted at roughly ₹2.19 Lakh Crore, with DAP 2026 timed to govern acquisition from the new financial year.
Export Momentum & FDI/Tech-Transfer Route	Defence exports have grown sharply across successive phases, led by platforms like BrahMos, Pinaka, and LCA Tejas components — the "Make in India, Make for the World" push (Ministry of Defence). FDI and joint-venture tech-transfer inflows are used strategically to secure local design rights and co-production, complementing the negative-list approach.

> **Summary**: Defence indigenization has moved beyond banning imports (negative lists) toward DAP 2026's structural preference for IDDM procurement and explicit pursuit of IP/design ownership — signalling that self-reliance now means owning the technology stack, not just assembling it domestically.

3. STRATEGIC SPACE & QUANTUM SOVEREIGNTY

Cue Words	Notes
Space Sector: IN-SPACe Reforms	**IN-SPACe** opened space activities to private players, attracting **150+ space startups** within three years — indigenization here means building a domestic private launch/satellite ecosystem, not just ISRO self-reliance. **Chandrayaan-3**: India became the first nation to land on the Lunar South Pole, on a budget of just **₹615 Crore**, showcasing cost-efficient indigenous engineering. **Aditya-L1** and the planned **Gaganyaan** (3-member crew, 400 km orbit, 3-day mission) extend this to solar observation and human spaceflight — both built on indigenous propulsion and life-support R&D.
Quantum & Supercomputing Sovereignty	**National Quantum Mission**: ₹6,003 Crore outlay to build quantum computers with 50-1000 physical qubits — targeting sovereign capability in a technology with direct cryptographic/defence implications. **National Supercomputing Mission (NSM)**: 24+ supercomputers deployed across institutions (e.g., Param Siddhi at 5.26 petaflops), reducing dependence on imported HPC access for weather, defence, and scientific modelling.

> **Summary**: In space and quantum computing, indigenization has shifted from single flagship missions to ecosystem-building — a private-sector-enabled space startup base and a dedicated quantum mission — both aimed at sovereign capability in technologies with strategic and dual-use value.

4. PHARMA, BIOSECURITY & PUBLIC-HEALTH SELF-RELIANCE

Cue Words	Notes
Pharma as an Indigenization Success Story	India is the **largest global provider of generic drugs**, exporting pharmaceuticals worth **$25 Billion** annually, and Indian firms supply **60% of WHO/UNICEF-distributed prequalified vaccines** worldwide. **CDSCO** regulatory auditing spans **10,000+ pharmaceutical units**, underpinning quality assurance that sustains export competitiveness.
Biosecurity & Regulatory Safety Nets	**Bhopal Gas Tragedy Act, 1985**: Restructures state liability, managing a compensation corpus of **₹1,500+ Crore** — a cautionary institutional backdrop for chemical/pharma indigenization. **One Health Mission**: Coordinates medical, veterinary, and environmental departments to pre-empt zoonotic spillover — indigenization of health security, not just of drug manufacturing.

> **Summary**: Pharma indigenization is India's most mature success case — deep manufacturing scale plus regulatory credibility (CDSCO) sustain export leadership — while newer frameworks like One Health extend self-reliance thinking from drug production to broader public-health resilience.

5. INDO-US iCET & GLOBAL TECHNOLOGY PARTNERSHIPS

Cue Words

Notes

iCET as a Calibrated Alternative to Pure Self-Reliance

**Indo-US iCET (initiative on Critical and Emerging Technologies)**, launched in 2023, co-develops defence, AI, and space technology — an acknowledgment that full self-reliance in frontier tech is neither feasible nor efficient, and that trusted-partner co-development can substitute for import substitution in select domains. This complements rather than replaces DAP 2026's IDDM push: iCET targets frontier co-design (jet engines, semiconductors), while DAP 2026 targets sovereign ownership of legacy and mid-tier platforms.

> **Summary**: iCET reflects a pragmatic recalibration of indigenization strategy — pooling R&D with a trusted partner on frontier technologies where India's base is thin, while DAP 2026 and the negative-list regime continue to push for outright domestic ownership elsewhere.

UPSC Mains PYQs

• Defence Indigenization Rationale: Discuss the objectives and significance of India's defence indigenization policy, referring to the negative import lists and the Buy (Indian-IDDM) category. (15 Marks, 250 Words)
• From Make in India to Owned by India: Critically examine the shift in India's defence procurement philosophy from domestic manufacturing to indigenous design ownership under the new Defence Acquisition Procedure. (15 Marks, 250 Words)
• R&D Funding Gap: India's R&D spending remains a fraction of that of major economies despite growing patent output. Analyse the structural reasons and suggest reforms to raise private-sector R&D investment. (10 Marks, 150 Words)
• Space Sector Privatization: Discuss how IN-SPACe reforms have altered India's space technology self-reliance strategy. (10 Marks, 150 Words)
• Strategic Technology Partnerships: Evaluate whether initiatives like the Indo-US iCET strengthen or dilute India's pursuit of technological self-reliance. (15 Marks, 250 Words)
• Pharma Self-Reliance: Discuss the factors behind India's success as the "pharmacy of the world" and the regulatory challenges in sustaining this position. (10 Marks, 150 Words)